| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 301408 from our risk checks.
Anhui Huaren Health Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.29 |
| 52 Week High | CN¥26.65 |
| 52 Week Low | CN¥9.94 |
| Beta | 0 |
| 1 Month Change | -3.59% |
| 3 Month Change | -22.72% |
| 1 Year Change | -36.86% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.39% |
Recent News & Updates
Shareholder Returns
| 301408 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | 4.8% | 2.0% | 2.1% |
| 1Y | -36.9% | -20.2% | -14.2% |
Return vs Industry: 301408 underperformed the CN Consumer Retailing industry which returned -21.2% over the past year.
Return vs Market: 301408 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 301408 volatility | |
|---|---|
| 301408 Average Weekly Movement | 8.0% |
| Consumer Retailing Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 301408's share price has been volatile over the past 3 months.
Volatility Over Time: 301408's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 5,785 | n/a | www.hrjkjt.com |
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, bruises bones disease, endocrine, heat-clearing, respiratory system, cold, anti-allergic, ophthalmology, antipyretic, analgesic, rheumatism pediatrics, skin, and gynecology, as well as provides vitamins and minerals, detoxifying, and antibacterial and anti-inflammatory products.
Anhui Huaren Health Pharmaceutical Co., Ltd. Fundamentals Summary
| 301408 fundamental statistics | |
|---|---|
| Market cap | CN¥4.52b |
| Earnings (TTM) | CN¥180.48m |
| Revenue (TTM) | CN¥3.70b |
25.0x
P/E Ratio1.2x
P/S RatioIs 301408 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301408 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.70b |
| Cost of Revenue | CN¥2.50b |
| Gross Profit | CN¥1.20b |
| Other Expenses | CN¥1.02b |
| Earnings | CN¥180.48m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | 0.45 |
| Gross Margin | 32.37% |
| Net Profit Margin | 4.87% |
| Debt/Equity Ratio | 23.3% |
How did 301408 perform over the long term?
See historical performance and comparison